News

Researchers at the VIB-KU Leuven Center for Cancer Biology have uncovered that "natural killer" cells (NK), ... The goal of the project was to apply single-cell multi‑omics and spatial profiling ...
Juvenile idiopathic arthritis (JIA), a type of arthritis commonly occurring in children, is a chronic, inflammatory condition ...
The growing prevalence of chronic diseases is a major factor driving revenue growth in the natural killer (NK) cell ...
Michael Green, PhD, discusses a new method of assessing lymphoma subtypes utilizing the tumor microenvironment.
The ability to analyze gene expression at the single-cell level—known as single-cell RNA sequencing (scRNA-seq)—has ...
These findings suggest that KIR2DS2-positive (KIR2DS2+) natural killer (NK) cells could be an attractive therapeutic target for in vivo strategies, although enhanced effector function is lost ...
The CAR-NK cell product studied in this trial - called FT596 - was developed by Fate Therapeutics, which funded the trial. ... which only targets the cancer cells in one way. ...
Several ASX-listed biotechs are advancing cell therapies to capture a share of a global market projected to reach US$48 ...
Researchers from more than 50 international institutions have launched Open Problems, a collaborative open-source platform to ...
One of these cell-types is appropriately called natural killer cells. All of us produce a growth factor—called IL-15—which effectively protects us from cancers.